HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshinari Minamoto Selected Research

Retinoblastoma Protein

12/2020Glycogen synthase kinase-3β participates in acquired resistance to gemcitabine in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshinari Minamoto Research Topics

Disease

61Neoplasms (Cancer)
01/2024 - 01/2002
16Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 08/2003
14Carcinogenesis
01/2020 - 08/2004
11Stomach Neoplasms (Stomach Cancer)
01/2023 - 03/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 03/2006
9Glioblastoma (Glioblastoma Multiforme)
11/2019 - 02/2009
9Colonic Neoplasms (Colon Cancer)
12/2016 - 01/2002
8Neoplasm Metastasis (Metastasis)
08/2023 - 03/2003
5Inflammation (Inflammations)
01/2020 - 07/2008
5Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2020 - 01/2006
3Glioma (Gliomas)
11/2019 - 01/2012
3Hyperplasia
01/2019 - 03/2009
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2009 - 02/2009
3Liver Neoplasms (Liver Cancer)
12/2009 - 01/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 12/2009
2Hyperthermia
08/2023 - 09/2010
2Sarcoma (Soft Tissue Sarcoma)
02/2020 - 11/2016
2Esophageal Squamous Cell Carcinoma
01/2020 - 06/2019
2Gastritis
01/2019 - 01/2019
2Lymphoma (Lymphomas)
09/2017 - 02/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2010 - 12/2009
2Type 2 Diabetes Mellitus (MODY)
12/2009 - 01/2006
2Adenocarcinoma
12/2009 - 01/2005
1Adenosquamous Carcinoma
01/2022
1Kidney Neoplasms (Kidney Cancer)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Adenoma (Adenomas)
11/2020
1CHARGE Syndrome
02/2020
1Fibrosarcoma
02/2020
1Synovial Sarcoma (Synovioma)
02/2020
1Dermatomyositis (Dermatopolymyositis)
06/2019

Drug/Important Bio-Agent (IBA)

16Glycogen Synthase KinasesIBA
01/2024 - 01/2006
13Proteins (Proteins, Gene)FDA Link
10/2023 - 08/2004
10Glycogen Synthase (Synthase I)IBA
08/2023 - 09/2007
10beta CateninIBA
10/2009 - 01/2002
8Messenger RNA (mRNA)IBA
12/2023 - 08/2004
8Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2005
8DNA (Deoxyribonucleic Acid)IBA
11/2021 - 02/2002
7Phosphotransferases (Kinase)IBA
11/2016 - 09/2005
6GemcitabineFDA Link
01/2024 - 03/2006
6Glycogen Synthase Kinase 3 betaIBA
12/2009 - 09/2005
5Temozolomide (Temodar)FDA LinkGeneric
11/2019 - 02/2009
4Transcription Factors (Transcription Factor)IBA
10/2023 - 06/2006
4Cyclin D1IBA
12/2020 - 03/2005
4ElementsIBA
02/2020 - 01/2005
4Therapeutic UsesIBA
01/2020 - 02/2009
4Tyrosine (L-Tyrosine)FDA Link
01/2020 - 02/2009
3Formaldehyde (Formol)FDA Link
01/2022 - 12/2012
3ParaffinIBA
01/2022 - 12/2012
3Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2022 - 12/2016
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2002
3CateninsIBA
11/2020 - 03/2012
3NucleotidesIBA
12/2016 - 07/2008
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2013 - 12/2009
3NF-kappa B (NF-kB)IBA
08/2007 - 08/2004
2Small Interfering RNA (siRNA)IBA
01/2023 - 10/2013
2CytokinesIBA
01/2022 - 03/2009
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022 - 11/2009
2Interleukin-1 (Interleukin 1)IBA
01/2022 - 01/2019
2Thymidylate SynthaseIBA
11/2021 - 12/2020
2Carrier Proteins (Binding Protein)IBA
02/2020 - 09/2017
2Cadherins (E-Cadherin)IBA
02/2020 - 03/2003
2Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 09/2005
2RNA (Ribonucleic Acid)IBA
01/2020 - 02/2019
2InterleukinsIBA
01/2019 - 03/2009
2Fluorouracil (Carac)FDA LinkGeneric
12/2016 - 08/2007
2N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA
10/2013 - 02/2009
2Nuclear Proteins (Protein, Nuclear)IBA
10/2012 - 03/2012
2AntralIBA
03/2011 - 12/2010
1NexusIBA
01/2024
1Ribosomal RNAIBA
12/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2023
1Galectin 4 (LGALS4)IBA
01/2023
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
01/2022
1Interleukin-33IBA
01/2022
1Threonine (L-Threonine)FDA Link
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
12/2020
1thymidine kinase 1IBA
12/2020
1E2F1 Transcription FactorIBA
12/2020
1Retinoblastoma ProteinIBA
12/2020
1Cyclin EIBA
02/2020
1RNA Precursors (Precursor, mRNA)IBA
02/2020
1CollagenIBA
02/2020
1hydrogen sulfite (bisulfite)IBA
01/2020
1Cyclin B1IBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1GlucocorticoidsIBA
01/2020
1kenpaulloneIBA
11/2019
1AntigensIBA
06/2019
1AutoantibodiesIBA
06/2019
1Complementary DNA (cDNA)IBA
06/2019

Therapy/Procedure

18Therapeutics
01/2024 - 03/2006
10Drug Therapy (Chemotherapy)
08/2023 - 08/2007
6Radiotherapy
08/2023 - 01/2011
2Immunotherapy
08/2023 - 08/2007
2Adjuvant Chemotherapy
11/2021 - 01/2011
2Lasers (Laser)
01/2019 - 04/2006